07:00 , Aug 22, 2016 |  BC Week In Review  |  Company News

Medivir, Trek Therapeutics deal

Medivir granted Trek exclusive, worldwide rights outside of Taiwan and China, including Hong Kong and Macau, to develop and commercialize MIV-802 . The pan-genotypic uridine nucleotide HCV NS5B polymerase inhibitor is in preclinical testing. Medivir...
07:00 , Aug 18, 2014 |  BC Week In Review  |  Company News

Medivir management update

Medivir AB (SSE:MVIR B), Huddinge, Sweden   Business: Infectious, Autoimmune, Musculoskeletal   Hired: Niklas Prager, a director, as president and CEO, effective Sept. 1, formerly chairman of BioPhausia AB , which Medivir acquired; Prager, who...
01:21 , Aug 12, 2014 |  BC Extra  |  Company News

Medivir names Prager CEO

Infectious disease company Medivir AB (SSE:MVIR B) hired Niklas Prager to succeed Maris Hartmanis as president and CEO, effective Sept. 1. Prager previously was chairman of BioPhausia, which Medivir acquired in 2011. He was then...
00:26 , Sep 27, 2011 |  BC Extra  |  Company News

Medivir names Hartmanis CEO

Infectious disease company Medivir AB (SSE:MVIR B) promoted Maris Hartmanis to president and CEO from deputy CEO and COO. He replaces Ron Long, who resigned. Hartmanis was CEO of Medivir's recently acquired BioPhausia AB subsidiary....
07:00 , Sep 5, 2011 |  BC Week In Review  |  Company News

Bluefish Pharmaceuticals, Medivir deal

Medivir's BioPhausia AB subsidiary sold its BMM Pharma AB generics subsidiary to generics company Bluefish for SEK38 million ($6 million) in cash. BioPhausia said the deal will allow it to focus on the commercial development...
07:00 , Sep 5, 2011 |  BC Week In Review  |  Company News

Medivir management update

Medivir AB (SSE:MVIR B), Huddinge, Sweden   Business: Infectious, Autoimmune, Musculoskeletal   Hired: Jens Kristensen as EVP of clinical, formerly CMO and VP of clinical development and regulatory affairs at Karo Bio AB   Transitioned:...
00:24 , Aug 31, 2011 |  BC Extra  |  Company News

Medivir deputizes Hartmanis, adds Karo's Kristensen

Infectious disease company Medivir AB (SSE:MVIR B) named Maris Hartmanis deputy CEO and COO. Hartmanis is the CEO of Medivir's recently acquired BioPhausia AB subsidiary (see BioCentury Extra, April 11) . Medivir also hired ex-...
07:00 , Jun 20, 2011 |  BC Week In Review  |  Company News

BioPhausia, Medivir deal

Medivir completed its previously announced subsequent tender offer to acquire specialty pharma BioPhausia in a cash and stock deal. As of June 14, 322.2 million shares (94%) have been tendered. Medivir said it will initiate...
07:00 , Jun 20, 2011 |  BioCentury  |  Analyst Picks & Changes

Analyst picks & changes

Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 6/17 cls BTG plc (LSE:BGC) Jefferies Philippa Gardner Upgrade Hold (from underperform) 2% 275.1p Gardner also raised her target to 240p from 200p after...
07:00 , Jun 6, 2011 |  BC Week In Review  |  Company News

BioPhausia, Medivir deal

Medivir completed its previously announced tender offer to acquire specialty pharma BioPhausia in a cash and stock deal that values BioPhausia at SEK1.65 per share, or about SEK565 million ($90.1 million). As of May 30,...